# Saliva-based Detection of CD44

> **NCT03148665** · — · COMPLETED · sponsor: **Joseph Califano** · enrollment: 85 (actual)

## Conditions studied

- Oral Cavity Squamous Cell Carcinoma
- Oropharynx Squamous Cell Carcinoma
- Squamous Cell Carcinoma of the Oropharynx
- Squamous Cell Carcinoma of the Head and Neck

## Interventions

- **DEVICE:** OncAlert

## Key facts

- **NCT ID:** NCT03148665
- **Lead sponsor:** Joseph Califano
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-14
- **Primary completion:** 2019-04-10
- **Final completion:** 2022-05-03
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2022-08-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03148665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03148665, "Saliva-based Detection of CD44". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03148665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*